CLEVELAND, Nov. 21, 2018 /PRNewswire/ -- ViewRay, Inc.
(Nasdaq: VRAY), maker of the world's first and only clinical
MRI-guided radiation therapy system, announced today the
appointment of Robert M. Fuchs as
Chief Human Resources Officer effective October 22, 2018. Mr. Fuchs has over 18
years of experience in leading human resources.
Prior to joining ViewRay, Rob was the Senior Vice President,
Global Human Resources Officer for Advanced Energy. Previously, he
served as Senior Vice President, Global Human Resources Officer for
Spectranetics.
"We are pleased to announce that Rob
Fuchs has been named our Chief Human Resources Officer,"
said Scott Drake, President and CEO.
"Attracting, developing, and retaining talent is a top priority for
ViewRay. Rob will play an instrumental role in this objective, and
his passion for people and performance make him an excellent
addition to our company."
As an inducement material to Mr. Fuchs' entering into employment
with ViewRay, ViewRay has agreed to grant Mr. Fuchs a total of
175,000 stock options, effective November
15, 2018. This award was granted in accordance with Nasdaq
Listing Rule 5635(c)(4), and has been approved by the Compensation
Committee of ViewRay's Board of Directors. It is subject to the
terms and conditions of ViewRay's 2015 Stock Incentive Plan and Mr.
Fuchs' award agreement. These terms include a service-based vesting
requirement, with the stock options vesting over four years.
These options are priced as of the closing trading price of
ViewRay's common stock on the effective date.
About ViewRay
ViewRay®, Inc. (Nasdaq:
VRAY), designs, manufactures and markets the MRIdian®
radiation therapy system. MRIdian is built upon a proprietary
high-definition MR imaging system designed from the ground up to
address the unique challenges and clinical workflow for advanced
radiation oncology. Unlike MR systems used in diagnostic radiology,
MRIdian's high-definition MR was purposely built to deliver
high-precision radiation without unnecessary beam distortion, and
consequently, help to mitigate skin toxicity and other safety
concerns that may otherwise arise when high magnetic fields
interact with radiation beams. ViewRay and MRIdian are registered
trademarks of ViewRay, Inc.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/rob-fuchs-joins-viewray-as-chief-human-resources-officer-300754129.html
SOURCE ViewRay, Inc.